Sriram Ryali Net Worth & Insider Trades

Sriram Ryali - Chief Financial Officer, Eiger Biopharmaceuticals, Inc

As of March 14, 2022

What is Sriram Ryali's Net Worth?

The current estimated net worth of Eiger Biopharmaceuticals, Inc's Chief Financial Officer, Sriram Ryali, is estimated to be about $22.76K . Sriram Ryali owns about 41,566 units of Eiger Biopharmaceuticals, Inc common stock. In the last 3 years at Eiger Biopharmaceuticals, Inc, Sriram Ryali has sold an estimated value of $12.68K worth.

What is Sriram Ryali's Past Insider Trading?

Sriram Ryali's largest purchase order was 1,250 units , worth over $13.85K on April 22, 2019. Sriram Ryali's largest sale order was 2,266 units , worth over $12.68K on March 14, 2022. In total, Sriram Ryali has made about 9 transactions over 3 years of their time at Eiger Biopharmaceuticals, Inc. Sriram Ryali usually trades in March, with the busiest year in 2021 and 2019.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Sriram Ryali's Salary in 2020?

As Chief Financial Officer of Eiger Biopharmaceuticals, Inc, Sriram Ryali has a total base salary of $381,550 . Sriram Ryali received compensation valued at about $801,559 in 2020 after becoming Chief Financial Officer. The vast majority of their compensation came in the form of option awards of $234,442 , other earnings, plans or compensations of $173,272 , and other compensation of $12,296 .

What is Sriram Ryali's' Mailing Address?

  • Mailing address is C/o Eiger Biopharmaceuticals, Inc. 2155 Park Blvd. Palo Alto CA 94306 CA

Eiger Biopharmaceuticals, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
David A. Cory 2020 $590,584 - - $829,564 $393,360 $16,671 $1,830,179
David A. Cory 2019 $565,833 - - $2,009,820 $285,000 $11,200 $2,871,853
Sriram Ryali 2020 $381,550 - - $234,442 $173,272 $12,296 $801,559
Sriram Ryali 2019 $335,000 - - $662,211 $117,250 $9,732 $1,124,193
Eldon Mayer 2020 $385,569 $100,000 $92,700 $1,199,520 $169,256 $2,328 $1,949,373
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1305253/000119312521137193/d146195ddef14a.htm

What are Eiger Biopharmaceuticals, Inc's Past Insider Trades?

Eiger Biopharmaceuticals, Inc's most recent insider trade came on August 18, 2022 by David Apelian who sold 5,000 units worth $49.03K . In the last 6 years, insiders at Eiger Biopharmaceuticals, Inc have sold an estimated value of $3.02M and bought an estimated value of $4.61M worth of shares. Insider trading is most common in March, with the busiest year in 2019. The most active traders at the company are John Thomas Dietz,  Eldon Mayer III, Ex VP & Chief Commerc. Officer,  and David Cory, President and CEO .

Eiger BioPharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1